CEO, COMPASS Pathways Part of our Year in Review series As COMPASS Pathways embarks on its ambitious Phase 3 program, which will evaluate its COMP360 psilocybin therapy in patients with treatment-resistant depression, we invited CEO Kabir Nath to share a short perspective piece. We’re currently living through a mental health crisis. Every 40 seconds, someone dies from suicide 1.
